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Abstract 
 
Background: In recent times, the hepatitis B virus surface antigen (HBsAg) level, a cheaper 
marker compared to the molecular method, has been used not only for indicating active 
hepatitis B virus (HBV) infection, but also for predicting the clinical and treatment outcomes. 
Chronic HBV (CHB) infection is related to defects in cells-mediated immunity; however, 
data linking the level of HBsAg with changes of immune response during a CHB infection is 
still lacking in Malaysia. Therefore, the aim of this study was to quantify the HBsAg level in 
CHB patients and to investigate its correlation with the immune status. 
Materials and methods: A total of 50 patients with CHB infection and 20 healthy controls 
were recruited for this cross-sectional study. Serological and biochemical analyses were 
performed on the serum samples. The HBV genotype was determined by direct sequencing 
and the viral load in the serum was measured using qPCR. The immunophenotype profiles of 
the peripheral blood lymphocyte were analyzed using flow cytometry and the HBsAg 
concentration was measured using Roche’s Elecsys HBsAg II assay. 
Results: The analyzed data demonstrated a narrowly higher mean level of bilirubin and liver 
enzymes exhibited by the viremic CHB patients compared to the healthy controls. In the viral 
load study, 15 patients had a high viral DNA load (≥ 3×106 genome copies/ mL), while 35 
patients had a low or undetectable viral load (< 3×106 genome copies/mL). The phylogenetic 
tree analysis for 35 detectable samples elucidated that the genotypes were B and C, and they 
were at equal prevalence rates. The outcome of the peripheral blood lymphocyte study 
revealed that the percentages of CD4+ and CD8+ cells were significantly reduced, while the 
CD4+/CD8+ ratio were observed to be slightly increased in the CHB patients compared to 
the healthy controls. At the same time, there were no statistically significant differences 
between the CHB patients and healthy controls with respect to other peripheral blood 
lymphocyte cells. More than half of the patients had HBsAg titre above 1000 IU/mL, and 
there was a positive and negative correlation between the HBsAg titre and the percentage of 
total T cell lymphocytes and natural killer cells, respectively. 
Conclusion: Our findings indicated that serum HBsAg suppressednatural killer cells 
population, but enhanced total T cells lymphocyte in response to CHB infection. This study 
has shown the importance of quantitative HBsAg as a laboratory biomarker that may help to 
define the immune state of CHB patients. 
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